Rates and predictors of 18-months remission in an epidemiological cohort of 661 patients with first-episode psychosis
Crossref DOI link: https://doi.org/10.1007/s00127-017-1388-7
Published Online: 2017-05-05
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Conus, Philippe http://orcid.org/0000-0002-5832-1910
Cotton, Sue
Schimmelmann, Benno G.
McGorry, Patrick D.
Lambert, Martin
Funding for this research was provided by:
Eli Lilly and Company Australia, investigator initiated trial
License valid from 2017-05-05